Clinical Trial Update: Cyclophosphamide and Busulfan as Conditioning Regimen Before Allogeneic HSCT [NA]

View source ↗

Summary

A completed clinical trial evaluated cyclophosphamide and busulfan as conditioning before allogeneic hematopoietic stem cell transplantation. The sponsor is Uni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoid Neoplasms
• Myelodysplastic Syndromes
• Myeloid Leukemia

Drugs mentioned

• BUSULFAN (Busulfan)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Myeloid Leukemia, Precursor Myeloid Neoplasms | NA | Status: COMPLETED